Loading
Latest filing published 04 Mar 2013 for STELLAR PHARMACEUTICALS INC, €77k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Arnold Tenney discloses dealings in Stellar Pharmaceuticals Inc to SEC (Form 4). Between 17 November 2006 and 27 February 2013, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €83k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. Since January 2013: 1 purchase and no sales on the market.
The latest filing, published on 4 March 2013, reports an open-market purchase of €77k in Stellar Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations